J. Guo

TRANxITION 144‐week results: switching virologically stable HIV patients from immediate‐release nevirapine (NVP IR) to extended‐release NVP (XR)

D. Ward, K. Arastéh, M. Drulak, 2012 .

Twenty‐four‐week efficacy and safety of switching virologically suppressed HIV‐1‐infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)

D. Ward, C. Orkin, C. Cordes, 2012, HIV medicine.

Twenty‐four‐week efficacy and safety of switching virologically suppressed HIV‐1‐infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)

K. Arastéh, A. Quinson, J. Livrozet, 2012, HIV medicine.